PRASHANT BARAKOTI: Open Payments
NPI 1801011598 · NORFOLK, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,377 in 98 payments from 19 companies in 2025. Trend: 2023 $3,181 · 2024 $3,629 · 2025 $3,377
Food & beverage: $3,377
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 13 | $570 |
| AstraZeneca Pharmaceuticals LP | 8 | $521 |
| Lilly USA, LLC | 13 | $437 |
| Amgen Inc. | 10 | $344 |
| ABBVIE INC. | 11 | $287 |
| Janssen Pharmaceuticals, Inc | 5 | $211 |
| PFIZER INC. | 10 | $204 |
| Corcept Therapeutics | 5 | $199 |
| GlaxoSmithKline, LLC. | 3 | $155 |
| Ardelyx, Inc. | 1 | $112 |
Products named: Wegovy, OTEZLA, FARXIGA, BREZTRI, MOUNJARO, SPRAVATO, Korlym, QULIPTA.
Industry payments across VA — which companies pay providers there.
